课题基金 / 基金详情

Genetics of Host Resistance and Susceptibillity to MTB

Genetics of Host Resistance and Susceptibillity to MTB
宿主对 MTB 的耐药性和易感性的遗传学
批准号:
8536988
负责人:
Igor Kramnik
金额:
$40.93万
依托单位国家:
美国
项目类别:
财政年份:
1997
资助国家:
美国
项目状态:
已结题
起止时间:
1997-09-30 至 2014-07-31

项目摘要

项目成果

Igor Kramnik的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Tuberculosis remains a significant public health problem, despite substantial effort to develop new drugs and vaccines in recent years. Host variation in terms of susceptibility to the infection is a major impediment to the development of universally efficient prevention and treatment strategies. This variation is partially explained by the genetic factors. In our studies mouse model of infection with virulent Mycobacterium tuberculosis (MTB) is used to dissect complex genetic control of host resistance to MTB and reveal genes, which strongly influence progression of tuberculosis infection in vivo. Our studies demonstrate that dramatic differences in tuberculosis susceptibility of two immunocompetent mouse strains C3HeB/FeJ and C57BL/6J mice are due to effects of several genetic loci and their epistatic interactions. To date, we have mapped nine tuberculosis resistance loci, dissected the sst1 locus and identified the Ipr1 gene by positional cloning. Synergisitic interactions of the sst1 with a novel locus on mouse chromosome 7 (Chr7) represent a major genetic component in our model, which accounts for about 50% of the variation between the parental strains. The cumulative effect of the two B6-derived resistance loci was remarkably stronger than the sum of their individual effects, providing the first direct experimental evidence of epistatic gene interactions in control of host resistance to MTB. Together the two loci increased the survival of the extremely susceptible C3HeB/FeJ mice from one month to 5 - 6 months post infection, greatly improved control of MTB growth and decreased lung inflammation. In this application we propose genetic and functional characterization of the Chr7 locus to identify causal gene using positional cloning and reveal its specific role in control of host resistance of tuberculosis infection. The candidate region will be reduced to 0.5 - 2 Mb interval using a set of subcongenic strains that we have developed. Haplotype structure, gene expression pattern and sequence analysis of the minimal candidate region will be used to identify top candidate genes. Functional analysis of the candidate gene will be performed using in vitro and in vivo assays to obtain definitive proof for its role in host resistance to MTB and characterize pathways that the candidate gene controls at molecular, cellular and whole organism levels. This will lead to a better understanding of how different pathways interact to produce resistant or susceptible phenotypes in immunocompetent hosts, an exploration of these pathways in humans and potentially provide molecular targets for correction of the susceptible phenotypes. PUBLIC HEALTH RELEVANCE: Tuberculosis remains a significant public health problem. To reduce the disease burden we must improve our understanding of how the pathogen destroys lungs of immunocompetent individuals and reveal environmental and genetic factors responsible for big differences among individuals in resistance to tuberculosis. We use genetic analysis in experimental mouse model of infection to identify genes, which effects strongly influence progression of tuberculosis infection in the lungs and have found two major host resistance loci, which synergistic effect dramatically reduce lung pathology and increase survival of the tuberculosis infected mice. We have previously characterized one of those loci, sst1, and found a candidate gene, which mediates innate immunity to tuberculosis. In this application we propose genetic and functional dissection of the second locus on chromosome 7 to isolate novel host resistance gene and reveal its function in control of tuberculosis infection.
期刊论文(18)
专著(0)
科研奖励(0)
会议论文
DOI: 10.1038/gene.2008.68
发表时间: 2009-01
期刊: GENES AND IMMUNITY
影响因子: 5
作者: [Sissons, J., Yan, B-S, Pichugin, A. V., Kirby, A., Daly, M. J., Kramnik, I.]
通讯作者: Kramnik, I.
Progression of pulmonary tuberculosis and efficiency of bacillus Calmette-Guérin vaccination are genetically controlled via a common sst1-mediated mechanism of innate immunity.
肺结核的进展和卡介苗疫苗接种的效率是通过常见的 sst1 介导的先天免疫机制进行基因控制的。
DOI: 10.4049/jimmunol.179.10.6919
发表时间: 2007
期刊: Journal of immunology (Baltimore, Md. : 1950)
影响因子: --
作者: [Yan,Bo-Shiun, Pichugin,AlexanderV, Jobe,Ousman, Helming,Laura, Eruslanov,EvgeniyB, Gutiérrez-Pabello,JoséA, Rojas,Mauricio, Shebzukhov,YuriyV, Kobzik,Lester, Kramnik,Igor]
通讯作者: Kramnik,Igor
Genetic dissection of pulmonary tuberculosis: implications for drug and vaccine development.
肺结核的基因剖析:对药物和疫苗开发的影响。
DOI: --
发表时间: 2012
期刊: Nihon Hansenbyo Gakkai zasshi = Japanese journal of leprosy : official organ of the Japanese Leprosy Association
影响因子: --
作者: [Kramnik,Igor]
通讯作者: Kramnik,Igor
DOI: 10.1186/1471-2105-10-409
发表时间: 2009-12-10
期刊: BMC bioinformatics
影响因子: 3
作者: [Aryee MJ, Gutiérrez-Pabello JA, Kramnik I, Maiti T, Quackenbush J]
通讯作者: Quackenbush J
8
    Necrosis in pulmonary TB granulomas: dynamics, mechanisms, therapies
    • 批准号:
      9028706
    • 项目类别:
    • 资助金额:
      $70.94万
    • 财政年份:
      2016
    • 负责人:
      Igor Kramnik
    • 依托单位:
    Necrosis in Pulmonary TB granulomas: dynamics, mechanisms, and therapies
    • 批准号:
      10446079
    • 项目类别:
    • 资助金额:
      $72.48万
    • 财政年份:
      2016
    • 负责人:
      Igor Kramnik
    • 依托单位:
    Necrosis in Pulmonary TB granulomas: dynamics, mechanisms, and therapies
    • 批准号:
      10584526
    • 项目类别:
    • 资助金额:
      $69.51万
    • 财政年份:
      2016
    • 负责人:
      Igor Kramnik
    • 依托单位:
    Novel TB Treatment Strategy - Optimization of Macrophage Responsiveness to IFNy
    • 批准号:
      9033071
    • 项目类别:
    • 资助金额:
      $49.11万
    • 财政年份:
      2013
    • 负责人:
      Igor Kramnik
    • 依托单位:
    海外基金